EXO NAD+
Korea's flagship all-in-one plant-based exosome skin rejuvenating solution with NAD+ complex.
Fifth-generation Korean exosomal skin enhancer — a multi-active professional formulation combining exosomes, lactic acid bacteria (lactobacillus ferment lysate), PDRN polynucleotide, and peptides in one advanced injectable aesthetic product. Positioned at the leading edge of Korean professional skin biotech.
LXC Lacto Exo Colla represents a fifth-generation approach to Korean professional aesthetic formulation — combining four established bioactive categories within a single professional product. The name reflects its key active quartet: Lacto (lactic acid bacteria / lactobacillus), Exo (exosomes), Colla (collagen-supporting peptides), with PDRN as the fourth major active contributor.
This multi-active format reflects the direction of advanced Korean aesthetic biotech — rather than single-active or dual-active formulations, LXC brings together four complementary biological systems with distinct but synergistic profiles. It represents a comprehensive skin quality intervention within a single professional aesthetic injectable.
Lactic acid bacteria ferment lysate — a well-established cosmetic bioactive with documented associations with skin microbiome balance, barrier support, and skin surface quality. Lactobacillus lysates have a longer evidence history in topical cosmetics and are increasingly incorporated into professional injectable formulations.
Botanical-origin exosome concentrate contributing the cellular signalling dimension of the formulation. Plant exosomes carry antioxidant compounds and signalling peptides associated with skin cellular communication in emerging research contexts.
Bioactive peptides associated with collagen synthesis support and skin firmness — a well-established category in cosmetic and aesthetic formulation with a broader evidence base than exosomes. Adds a structural skin quality dimension to the formulation's biological profile.
Salmon DNA-derived polynucleotide — the most evidentially mature active in the formulation with a relatively established aesthetic medicine literature base for tissue support, skin hydration, and skin quality. Adds a proven-category anchor to the formulation's advanced multi-active approach.
Regulatory Notice: LXC Lacto Exo Colla is a professional aesthetic product. Not a pharmaceutical drug. No FDA, EMA, or equivalent drug regulatory approval. Evidence maturity varies by active ingredient — PDRN and peptides have relatively established aesthetic literature; exosomes are emerging; lactobacillus lysate is well-documented in topical contexts but less so in injectable formats. For professional use only.
Korea's flagship all-in-one plant-based exosome skin rejuvenating solution with NAD+ complex.
Dual-technology human-derived formulation — PDRN polynucleotide science plus exosome signalling for comprehensive skin restoration.
Triple-action plant-based exosome complex for post-microneedling skin support and recovery protocols.
The Korean professional aesthetics market uses generational terminology to describe the evolution of skin booster and injectable bioactive formulations. Earlier "generations" typically refers to simpler HA-based or single-active products; subsequent generations added PDRN, then growth factors, then exosomes, then multi-active combinations. LXC's fifth-generation positioning reflects its integration of four distinct bioactive categories — exosomes, lactobacillus, PDRN, and peptides — representing the current leading edge of Korean multi-active professional aesthetic formulation. This is a marketing framework rather than a formal scientific classification.
Lactobacillus ferment lysate (lactic acid bacteria lysate) is well-established in topical cosmetics for its associations with skin barrier support, mild exfoliation, and microbiome-relevant activity. Its inclusion in injectable professional aesthetic formulations is a more recent development, reflecting the broader interest in microbiome-skin biology within the Korean aesthetic biotech sector. Evidence for injectable lactobacillus lysate is less developed than for topical application; practitioners should review the available data and manufacturer clinical documentation.
A single-active PDRN product delivers a focused polynucleotide payload with a well-established evidence base. LXC builds on PDRN as its evidentially anchored active and adds three additional biological layers — exosomes for cellular signalling, lactobacillus for microbiome and barrier context, and peptides for collagen-synthesis support. This multi-active approach is designed to provide broader skin quality coverage per session. Practitioners who prefer a more focused, single-active approach may prefer a dedicated PDRN product; those seeking a comprehensive multi-active protocol may favour LXC's broader formulation.
Available exclusively to verified professional clinics and wholesale partners. Request pricing, clinical data sheets, and protocol guides.